Skip to main content
Caplight Logo









Leukocare

Leukocare

Private
GermanyHealthcare & Life Scienceshttps://www.leukocare.com/

Last Round

VC Round

Jun 23, 2021

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Leukocare is a biotechnology company that provides a technology platform for biopharmaceutical formulation development to improve the stability and quality of biologics like vaccines, antibodies, and viral vectors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

formulation developmentbiopharmaceutical formulationbiologic stabilitylyophilization servicesfreeze-dryingcontract research organizationCROCDMOviral vector formulationvaccine formulationadvanced therapy medicinal productsATMPsAI for drug formulationstability studiesbioinformatics servicesexcipient selectionprimary packaging services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Leukocare Comparables

Compare Leukocare with similar companies based on industry and business-model similarity.

Leukocare comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ProJect Pharmaceutics GmbH
87%
Coriolis Pharma
87%
Pensatech Pharma GmbH
74%

Leukocare Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 23, 2021
VC RoundJul 22, 2015

Key People

Founding team and executive leadership

Michael Scholl

CEO

Executive Team

Leukocare Investors

Notable investors and investment history

Leukocare investors
InvestorRounds
LifeCare PartnersVC Round
Petrichor Healthcare Capital ManagementVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 1, 2026

    Open roles increased to 46, 82% of headcount.

  • Jul 20, 2026

    Open roles increased to 45, 80% of headcount.

Leukocare Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Leukocare Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Leukocare's valuation, stock price, and market status.

Firmographic Details

HeadquartersGermany
Employee Range55
Year Founded2003
Last FundingJun 23, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?